BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3220102)

  • 1. Activation of rat complement by soluble and insoluble rat IgA immune complexes.
    Rits M; Hiemstra PS; Bazin H; Van Es LA; Vaerman JP; Daha MR
    Eur J Immunol; 1988 Dec; 18(12):1873-80. PubMed ID: 3220102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the alternative pathway of complement by human serum IgA.
    Hiemstra PS; Gorter A; Stuurman ME; Van Es LA; Daha MR
    Eur J Immunol; 1987 Mar; 17(3):321-6. PubMed ID: 3569402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune complex modulation by plasma proteins. With special reference to the complement system and autoimmune diseases.
    Baatrup G
    Dan Med Bull; 1989 Oct; 36(5):443-63. PubMed ID: 2530063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymeric IgA and IgA rheumatoid factor decrease the capacity of serum to solubilize circulating immune complexes in patients with primary IgA nephropathy.
    Schena PF; Pastore A; Sinico RA; Montinaro V; Fornasieri A
    J Immunol; 1988 Jul; 141(1):125-30. PubMed ID: 3379302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylation of IgA is required for optimal activation of the alternative complement pathway by immune complexes.
    Zhang W; Lachmann PJ
    Immunology; 1994 Jan; 81(1):137-41. PubMed ID: 8132210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of immune complexes by the classical pathway.
    Whaley K; Ahmed AE
    Behring Inst Mitt; 1989 Jul; (84):111-20. PubMed ID: 2529842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of immune precipitation by purified components of the alternative pathway.
    Naama JK; Holme E; Hamilton E; Whaley K
    Clin Exp Immunol; 1985 Apr; 60(1):169-77. PubMed ID: 3159522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of rat complement by soluble and insoluble immune complexes of rat IgA.
    Rits M; Hiemstra PS; Bazin H; van Es LA; Daha M; Vaerman JP
    Monogr Allergy; 1988; 24():129-33. PubMed ID: 3362139
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction of C3 with antigen-antibody complexes in the process of solubilization of immune precipitates.
    Takata Y; Tamura N; Fujita T
    J Immunol; 1984 May; 132(5):2531-7. PubMed ID: 6232320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat C3 conversion by rat anti-2,4,dinitrophenyl (DNP) hapten IgA immune precipitates.
    Rits M; Kints JP; Bazin H; Vaerman JP
    Scand J Immunol; 1987 Apr; 25(4):359-66. PubMed ID: 3576132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble and insoluble immune complexes activate human neutrophil NADPH oxidase by distinct Fc gamma receptor-specific mechanisms.
    Crockett-Torabi E; Fantone JC
    J Immunol; 1990 Nov; 145(9):3026-32. PubMed ID: 2170530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monomeric immunoglobulin A protects glomerulus against polymeric immunoglobulin A immune complex in experimental immunoglobulin A nephropathy.
    Chen A; Sheu LF; Ding SL; Lee WH
    Lab Invest; 1996 Apr; 74(4):737-46. PubMed ID: 8606484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of rat IgM to IgG hybridoma isotype switch variants and analysis of the efficiency of rat Ig in complement activation.
    Pluschke G; Bordmann G; Daoudaki ME; Lambris JD; Achtman M; Neibert M
    Eur J Immunol; 1989 Jan; 19(1):131-5. PubMed ID: 2646134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the alternative pathway of complement by twelve different rabbit-mouse chimeric transfectoma IgA isotypes.
    Schneiderman RD; Lint TF; Knight KL
    J Immunol; 1990 Jul; 145(1):233-7. PubMed ID: 2358675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of complement activation by human IgA immune complexes.
    Imai H; Chen A; Wyatt RJ; Rifai A
    Clin Exp Immunol; 1988 Sep; 73(3):479-83. PubMed ID: 3061690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of complement activity by immunoglobulin. I. Effect of immunoglobulin isotype on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexes.
    Miletic VD; Hester CG; Frank MM
    J Immunol; 1996 Jan; 156(2):749-57. PubMed ID: 8543829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement depletion abolishes IgA-mediated glomerular inflammation in rats.
    Stad RK; van Gijlswijk-Janssen DJ; van Es LA; Daha MR
    Exp Nephrol; 1994; 2(3):182-9. PubMed ID: 7922271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative inefficiency of terminal complement activation.
    Bhakdi S; Fassbender W; Hugo F; Carreno MP; Berstecher C; Malasit P; Kazatchkine MD
    J Immunol; 1988 Nov; 141(9):3117-22. PubMed ID: 3262681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat polymeric IgA binds C1q, but does not activate C1.
    Hiemstra PS; Rits M; Gorter A; Stuurman ME; Hoekzema R; Bazin H; Vaerman JP; van Es LA; Daha MR
    Mol Immunol; 1990 Sep; 27(9):867-74. PubMed ID: 2215479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.